Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-26
1998-11-17
Mosley, Terressa
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514317, 514330, 514535, 514540, 514626, 514826, 514914, A01N 4340
Patent
active
058377131
ABSTRACT:
A therapeutic method is provided to treat an eosinophil-associated pathology, such as bronchial asthma, by administering to a mammal in need of such treatment, an effective amount of at least one topical anesthetic, such as lidocaine, with an effective amount of one or more glucocorticoids, or the pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 4466973 (1984-08-01), Rennie
patent: 4626530 (1986-12-01), Schulte
patent: 4748022 (1988-05-01), Busciglio
patent: 5134166 (1992-07-01), Bernstein
patent: 5510339 (1996-04-01), Gleich et al.
patent: 5631267 (1997-05-01), Gleich et al.
"Merck Manual", 14th Ed., pp. 622-627, (1982).
"Remington's Pharmaceutical Sciences", Mack Publishing Co., Eaton Pennsylvania, pp. 1051-1052, (1985).
Ayars, G.H., et al., "Injurious Effect of the Eosinophil Peroxide-Hydrogen Peoxide-Halide System and Major Basic Protein on Human Nasal Epithelium in vitro", Am. Rev. Resp. Dis., 140, pp. 125-131, (1989).
Barnes, P.J., "Asthma as an Axon Reflex", The Lancet, 1, pp. 242-244, (Feb. 1, 1986).
Bascom, R., et al., "Major Basic Protein and Eosinophil-Derived Neurotoxin Concentrations in Nasil-Lavage Fluid After Antigen Challenge: Effect of Systemic Corticosteroids and Relationship to Eosinophil Influx", J. Allergy Clin. Immunol., 84, pp. 338-346, (1989).
Butterfield, J.H., et al., "Chapter 8: Anti-Inflammatory Effect of Glucocorticoids on Eosinophils and Neutrophils", Anti-Imflammatory Steroid Action: Basic and Clinical Aspects, Schleimer et al., editors, Academic Press Inc., Schleimer, R.P., et al., (eds.), Academic Press, Inc., San Diego, p. 151-198, (1980).
Chen, W.Y., et al., "Effects of Inhaled Lidocaine on Exercise-Induced Asthma", Respiration, 51, 2, pp. 91-97, (1987).
Downes, H., et al., "Lidocaine Aerosols Do Not Prevent Allergic Bronchoconstriction", Anesth. Anag., 60, pp. 28-32, (1981).
Dunnill, M.S., "The Pathology of Asthma, with Special Reference to Changes in the Bronchial Mucosa", J. Clin. Path., 13, pp. 27-33, (1960).
Ellis, A.G., et al., "The Pathological Anatomy of Bronchial Asthma", Am. J. Med. Sci., 136, pp. 407-429, (1908).
Ennight, P.L., et al., "Effect of Lidocaine on the Ventilatory and Airway Response to Exercise in Asthmatics", Am. Rev. Resp. Disease, 122, pp. 823-828, (1980).
Filley, W., et al., "Indentification by Immunoflurescence of Eosinophil Granule Major Basic Protein in Lung Tissues of Patents with Broncial Asthma", The Lancet, 2, pp. 11-16 (1982).
Frigas, E., et al., "Cytotoxic Effects of the Guinea Pig Eosinophil Major Basic Protein on Tracheal Epithelium", Lab. Invest., 42, 35-43 (1980).
Frigas, E., et al., "Elevated Levels of the Eosinohil: Granule Major Basic Protein in the Sputum of Patents with Bronchial Asthma", Mayo Clinic. Proc. 56, pp. 345-353, (1981).
Fujisawa, T., et al., "Regulatory Effects of Cytokines on Eosinohil Degranulation", J. Immunol., 144, pp. 642-646, (1990).
Gleich, G.J., "Cytoxic Properties of the Esinophil Major Basic Protein", J. Immunol., 123, pp. 2925-2927, (1979).
Gleich, G.J., "Identification of a Major Basic Protein in Guinea Pig Eosinophil Granules", J. Exp. Med., 137, pp. 1459-1471, (1973).
Gleich, G.J., et al., "The Eosinophilic Leukocyte: Structure and Function", Adv. Immunol., 39, pp. 177-253 (1986).
Gross, N.J., et al., "Chapter 34: Anticholinergic Drugs", Allergy, Principles and Practice, vol. 1, E. Middleton Jr. et al., (ed.) The C.V. Mosby Company, pp. 782-808, (1988).
Gundel, R.H., et al., "Repeated Antigen Inhalation Results in a Prolonged Airway Eosinophilia and Airway Hyperresponsiveness in Primates", J. Appl. Physiol., 68, pp. 779-786 (1990).
Hamid, Q., et al., "Expression of mRNA for Interleukin-5 in Mucosal Bronchial Biopsies from Asthma", J. Clin. Invest., 87, pp. 1541-1546 (1991).
Harlin, S.L., et al., "A Clinical and Pathologic Study of Chronic Sinusitis: The Role of the Eosinophil", J. Allergy Clin. Immunol., 81, pp. 867-875 (1988).
Hastie, A.T., et al., "The Effect of Purified Human Ecsinophil Major Basic Protein on Mammalian Ciliary Activity", Am. Rev. Resp. Dis., 135, pp. 845-853 (1987).
Horn, B.R., et al., "Total Eosinophil Counts in the Management of Bronchial Asthma", N. Engl. J. Med., 292, pp. 1152-1155 (1975).
Krasnowska, M., et al., Translation of "A Test of Lidocaine Usage in the Treatment of Bronchial Asthma", Pneum. Pol., 50, 269-273 (1982).
Lamas, A.M., et al., "Glucocorticoids Specifically Decrease Eosinophil Survival", J. Allergy Clin. Immunol., 85, Abstract No. 554, p. 282, (1990).
Lamas, A.M., et al., "Human Endothelial Cells Prolong Eosinophil Survival", J. Immunol., 142, pp. 3978-3984, (1989).
Mauser, P.J., et al., "The Effect of Anti-Il-5 on Antigen-Induce Airway Hyperreactivity and Pulmonary Eosinophilia in Guinea Pigs", Am. Rev. Respir. Dis., 145, p. A859, (1992).
Motojima, S., et al., "Toxicity of Eosinophil Cationic Proteins for Guinea Pig Tracheal Epithelium in Vitro", Am. Rev. Resir. Dis., 139, pp. 801-805, (1989).
Rothenberg, M.E., et al., "Human Eosinophil have Prolonged Survival, Enhanced Functional Properties, and Become Hypodense when Exposed to Human Interleukin 3", J. Clin. Invest., 81, pp. 1986-1992, (1988).
Schleimer, R.P., et al., "Effects of Glucocorticosteroids on Inflammatory Cells Relevant to Their Therapuetic Applications in Asthma", Am. Rev. Respir., Dis., 141, pp. S59-S69, (1990).
Sedgwich, J.B., et al., "Immediate and Late Airway Response of Allergic Rhinitis Patients to Segmental Antigen Challenge", Am. Rev. Respir. Dis., vol. 144, No. 6, pp. 1274-1281, (1991).
Sehmi, R., et al., "Interleukin-5 Selectively Enhances the Chemotatics Response to Eosinophils Obtained from Normal but not Eosinophilic Subjects", Blood, 79, pp. 2952-2959, (1992).
Silberstein, D.S., et al., "Enhancement of Human Eosinophil Cytoxicity and Leukotriene Synthesis by Biosynthetic (Recombinant) Granulocyte-Macrophage Colony-Stimulating Factor", J. Immunol., 137, pp. 3290-3294, (1986).
Silberstein, D.S., et al., "Hemopoietins for Eosinophils", Hematol. Oncol. Clin. North Am., 3, pp. 511-513, (1989).
Trocme, S.D., et al., "Conjunctival Deposition of Eosinophil Granule Major Basic Protein in Vernal Keratoconjunctivitis and Contact Lens-Associated Giant Papillary Conjuctivitis", Am. J. Ophthamol., 108, pp. 57-63, (1989).
Tullett, W.M., "Effect of Lignocaine, Sodium Cromoglycate, and Ipratropium Bromide in Exercise-induced Asthma", Thorax, 37, pp. 737-740, (1982).
Udell, I.J., et al., "Eosinophil Granule Major Basic and Protein and Charot-Leyden Crystal Protein in Human Tears", Am. J. Opthamol., 92, pp. 824-828, (1981).
Valerius, T., et al., "Effects of IFN on Human Eosinophils in Comparison with Other Cytokines", J. Immunol, 145, pp. 2950-2958, (1990).
Wallen, N., et al., "Glucocorticoids Inhibit Cytokine-Mediated Eosinohpil Survival", J. Immunol., 147, pp. 3490-3495, (1991).
Wardlaw, A.J., et al., "Eposinophils and Mast Cells in Bronchoalveolar Lavage in Subjects with Mild Asthma", Am. Rev. Resp. Dis., 137, pp. 62-69, (1988).
Wasmoen, T.L., et al., "Biochemical and Amino Acid Sequence Analysis of Human Eosinophil Granule Major Basic Protein", J. Biol. Chem., 263, pp. 12559-12563, (1988).
Mayo Foundation for Medical Education and Research
Mosley Terressa
LandOfFree
Treatment of eosinophil-associated pathologies by administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of eosinophil-associated pathologies by administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of eosinophil-associated pathologies by administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-884720